Cargando…
IgE Sialylation is a Determinant of Allergic Pathogenicity
Approximately one-third of the world’s population suffers from allergies(1). Allergen exposure crosslinks mast cell- and basophil-bound immunoglobulin E (IgE), triggering the release of inflammatory mediators, including histamine(2). Although IgE is absolutely required for allergies, it is not under...
Autores principales: | Shade, Kai-Ting C., Conroy, Michelle E., Washburn, Nathaniel, Kitaoka, Maya, Huynh, Daniel J., Laprise, Emma, Patil, Sarita, Shreffler, Wayne, Anthony, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386252/ https://www.ncbi.nlm.nih.gov/pubmed/32499653 http://dx.doi.org/10.1038/s41586-020-2311-z |
Ejemplares similares
-
A single glycan on IgE is indispensable for initiation of anaphylaxis
por: Shade, Kai-Ting C., et al.
Publicado: (2015) -
Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions
por: Petry, Janina, et al.
Publicado: (2020) -
Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells
por: Hu, Jiayun, et al.
Publicado: (2018) -
A chimeric IgE that mimics IgE from patients allergic to acid-hydrolyzed wheat proteins is a novel tool for in vitro allergenicity assessment of functionalized glutens
por: Tranquet, Olivier, et al.
Publicado: (2017) -
Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)